|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| A61K 39/395 | (2006.01) |
| (11) | Number of the document | 3071220 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14802642.0 |
| Date of filing the European patent application | 2014-11-21 | |
| (97) | Date of publication of the European application | 2016-09-28 |
| (45) | Date of publication and mention of the grant of the patent | 2019-12-25 |
| (46) | Date of publication of the claims translation | 2020-02-25 |
| (86) | Number | PCT/EP2014/075315 |
| Date | 2014-11-21 |
| (87) | Number | WO 2015/075194 |
| Date | 2015-05-28 |
| (30) | Number | Date | Country code |
| 13193953 | 2013-11-21 | EP | |
| 2834000 | 2013-11-21 | CA | |
| 201314086696 | 2013-11-21 | US | |
| 201414182776 | 2014-02-18 | US |
| (72) |
LOIBNER, Hans, AT
MUTSCHLECHNER, Oliver, AT
LADENSTEIN, Ruth, AT
KLIER, Isabel, AT
|
| (73) |
Apeiron Biologics AG,
Campus-Vienna-Biocenter 5, 1030 Wien,
AT
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Preparatai, skirti gydyti GD2 gerybinį vėžį |
| PREPARATIONS FOR TREATING A GD2 POSITIVE CANCER |
| Payment date | Validity (years) | Amount | |
| 2025-10-21 | 12 | 289.00 EUR |
| 2026-11-21 |